Exalpha Biologicals Leases Lab Space In Shirley
Exalpha Biologicals, which conducts biological research and development for the medical industry, has leased 6,000 square feet of lab space in Shirley's Phoenix Park.
Banker & Tradesman,
Wed Dec 02 10:32:50 PST 2009
• Found on Yahoo! News
Research and Markets: Human Vaccines - Global Market Opportunities
DUBLIN----Research and Markets has announced the addition of the "Human Vaccines - Global Market Opportunities" report to their offering.
Business Wire via Yahoo! Finance,
Fri Dec 04 07:51:00 PST 2009
• Found on Yahoo! News
Topix.net
360,000 news channels, from Autos to your ZIP code.
• Found on Topix News
NOVAVAX Reports Positive Clinical Results From Pivotal Study Of H1N1 Influenza Vac...
Novavax, Inc. (Nasdaq: NVAX) reported favorable initial results from the first stage of a two-stage pivotal Phase II study evaluating the safety and immunogenicity of the company's 2009 H1N...
Medical News Today,
Thu Dec 03 06:11:46 PST 2009
• Found on Yahoo! News
GSK's Arepanrix H1N1 Pandemic Vaccine Prequalified By The World Health Organizatio...
GlaxoSmithKline (GSK) recently announced that the World Health Organization (WHO) has awarded prequalification for global use of Arepanrix, GSK's adjuvanted H1N1 pandemic vaccine manufactur...
PharmaceuticalOnline,
Wed Dec 02 22:53:35 PST 2009
• Found on Yahoo! News
WHO awards prequalification for global use of GSK's adjuvanted H1N1 pandemic vacci...
GlaxoSmithKline (GSK) announced that the World Health Organization (WHO) has awarded prequalification for global use of Arepanrix, GSK
PharmaBiz,
Wed Dec 02 19:51:25 PST 2009
• Found on Yahoo! News
Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Su...
SHANGHAI, Dec. 2 /PRNewswire-Asia/ -- The world is going through extraordinary times; markets are in turmoil and uncertainty is part of many businesses and industries.
redOrbit,
Wed Dec 02 08:09:41 PST 2009
• Found on Yahoo! News
Another seasonal flu vaccine on way to US market
Dec 2, 2009 (CIDRAP News)
Center for Infectious Disease Research and Policy,
Wed Dec 02 16:50:03 PST 2009
• Found on Yahoo! News
East Stroudsburg University Announces New Professional Graduate Degree In Master O...
East Stroudsburg University has announced its intention to create a new professional graduate degree, the Master of Science in Pharmaceutical Technology. This two year program is for studen...
BioresearchOnline,
Wed Dec 02 03:37:51 PST 2009
• Found on Yahoo! News
AMT Announces Management Changes in Light of Refocused Strategy
AMSTERDAM, December 2 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today a number of management changes...
redOrbit,
Tue Dec 01 23:09:27 PST 2009
• Found on Yahoo! News
Press Release
GlaxoSmithKline (GSK) today announced that the World Health Organization (WHO) has awarded prequalification for global use of Arepanrix
PharmiWeb,
Wed Dec 02 01:55:46 PST 2009
• Found on Yahoo! News
Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Su...
The world is going through extraordinary times; markets are in turmoil and uncertainty is part of many businesses and industries. It turns out that the pharma industry has been relatively i...
PR Newswire via Yahoo! Finance,
Wed Dec 02 06:00:00 PST 2009
• Found on Yahoo! News
NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vac...
Novavax, Inc. today reported favorable initial results from the first stage of a two-stage pivotal Phase II study evaluating the safety and immunogenicity of the company's 2009 H1N1 virus-l...
PR Newswire via Yahoo! Finance,
Wed Dec 02 05:05:00 PST 2009
• Found on Yahoo! News
AMT Announces Management Changes in Light of Refocused Strategy
Amsterdam Molecular Therapeutics , a leader in the field of human gene therapy, announced today a number of management changes. Piers Morgan has been appointed Chief Financial Officer, effe...
PR Newswire via Yahoo! Finance,
Tue Dec 01 22:00:00 PST 2009
• Found on Yahoo! News
World Health Organization certifies GSK's H1N1 vaccine
GlaxoSmithKline says one of its swine flu vaccines has been certified by the World Health Organization, making it available for use in developing countries.
WRAL.com Raleigh,
Tue Dec 01 05:44:03 PST 2009
• Found on Yahoo! News
Novavax Completes Enrollment In Phase IIa Study Of Seasonal Influenza Vaccine In O...
Novavax, Inc. (Nasdaq: NVAX ) announced today it has completed enrollment in the Phase II clinical study of its trivalent seasonal influenza (2008/2009 recommended strains) VLP vaccine cand...
PharmaceuticalOnline,
Tue Dec 01 03:38:25 PST 2009
• Found on Yahoo! News
NOVAVAX Completes Enrollment In Phase IIa Study Of Seasonal Influenza Vaccine In O...
Novavax, Inc. (Nasdaq: NVAX) announced it has completed enrollment in the Phase II clinical study of its trivalent seasonal influenza (2008/2009 recommended strains) VLP vaccine candidate i...
Medical News Today,
Tue Dec 01 04:42:06 PST 2009
• Found on Yahoo! News
/C O R R E C T I O N -- Latitude Solutions, Inc./
Latitude Solutions, Inc. , , announced today that its wholly-owned subsidiary, Latitude CleanTech Group, Inc., has signed a strategic partnership agreement with DCR, Inc., an Alberta, Canad...
CNW Group via Yahoo! Finance,
Tue Dec 01 11:33:00 PST 2009
• Found on Yahoo! News
World Health Organization certifies GSK
Get the latest news alerts: Follow LTW at Twitter. RESEARCH TRIANGLE PARK, N.C.
Local Tech Wire,
Tue Dec 01 04:19:18 PST 2009
• Found on Yahoo! News
/C O R R E C T I O N -- Latitude Solutions, Inc./
Dec-2009 by Latitude Solutions, Inc. over PR Newswire, the ticker in the first sentence should read "LATI" rather than "LTI" as incorrectly transmitted by PR Newswire. The complete, correct...
PR Newswire via Yahoo! Finance,
Tue Dec 01 07:00:00 PST 2009
• Found on Yahoo! News